{
  "actions": [
    {
      "acted_at": "2000-07-11T13:30:00-04:00", 
      "references": [
        {
          "reference": "CR H5775-5777", 
          "type": "consideration"
        }, 
        {
          "reference": "CR H5775", 
          "type": "text"
        }
      ], 
      "text": "Amendment (A036) offered by Mr. Brown (OH).", 
      "type": "action"
    }, 
    {
      "acted_at": "2000-07-11T13:39:00-04:00", 
      "references": [], 
      "text": "By unanimous consent, the Brown (OH) amendment was withdrawn.", 
      "type": "action"
    }
  ], 
  "amendment_id": "hamdt975-106", 
  "amendment_type": "hamdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "hr4461-106", 
    "bill_type": "hr", 
    "congress": 106, 
    "number": 4461
  }, 
  "amends_treaty": null, 
  "chamber": "h", 
  "congress": "106", 
  "description": null, 
  "house_number": 36, 
  "introduced_at": "2000-07-11", 
  "number": 975, 
  "purpose": "An amendment numbered 37 printed in the Congressional Record to add a provision to the bill that prohibits the use of funds from being used to approve any application for a new drug submitted by an entity that does not agree to a quarterly disclosure of the average price charged by the manufacturer for the most common dosage of the drug in each country that is a member of OECD.", 
  "sponsor": {
    "district": "13", 
    "name": "Brown, Sherrod", 
    "state": "OH", 
    "thomas_id": "00136", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "offered", 
  "status_at": "2000-07-11", 
  "updated_at": "2013-07-17T08:15:43-04:00"
}